http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NI-201100181-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4525
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4523
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04
filingDate 2011-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c67054c8172c6c6e4250d9c5bf56a06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b6416acf92fce301d720a4e6f7afcb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9b75e5812e079d257695c9498d23b20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47041c6d530ff8f7115818cb1debd1e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06c3dc560048e5e270ee371c42c0e0c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dee203c546058de699fc3b04bd19e66e
publicationDate 2012-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NI-201100181-A
titleOfInvention ISOXAZOLE ANALOGUES - 3 (2H) -ONE AS THERAPEUTIC AGENTS
abstract A compound of Formula I or a pharmaceutically acceptable salt thereof, where R1 and R2 are independently hydrogen, deuterium, aryl, heteroaryl, C1-C8 alkyl, and are optionally substituted with one or more substituents that are independently R3, R3 is an aryl , heteroaryl, one or more fluorine atoms, a C1-C6 alkyl containing one or more fluorine atoms, a C1-C6 alkyl containing one or more deuterium atoms, a C1-C6 alkyl containing hydroxy, the aryl being and heteroaryl optionally substituted with one or more halogens, a fluorinated alkoxy, a fluorinated alkyl, a sulfonyl, one or more deuterium atoms, a C1-C6 alkyl, a C1-C6 alkoxy, a nitrile, or R3 is a C1 alkyl -C6 optionally substituted with one or more of the following groups: COOR4, OCOR4, CONR5R6, NR5COR6, OR4; where R4 is a C1-C10 alkyl optionally substituted with one or more fluorine, deuterium, alkoxy, aryl carboxylate, alkyl carboxylate atoms; R5 and R6 are independently selected from hydrogen, alkyl, or may together form a 4-8 membered carbon ring; or R1 and R2 form a 3-10 membered carbon ring optionally comprising O or N and is optionally substituted with a C1-C10 alkyl or aryl, heteroaryl optionally substituted with R3.
priorityDate 2009-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457280508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455581532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9254
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559591
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408088710
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID167583

Total number of triples: 36.